Transcatheter Aortic Valve Implantation: Comparison of the Effects of Ultrasound-Guided Pericapsular Nerve Group Block and Fascia Iliaca Block on Postoperative Analgesia Management

Launched by MEDIPOL UNIVERSITY · Jan 12, 2025

Keywords

ClinConnect Summary

This clinical trial is studying two different methods of pain relief for patients undergoing a procedure called Transcatheter Aortic Valve Implantation (TAVI), which is used to treat a heart condition known as aortic stenosis. The researchers want to find out which method—an ultrasound-guided nerve block called Pericapsular Nerve Group Block (PENG) or another method called Fascia Iliaca Block (FIB)—works better for managing pain after the surgery. Both methods aim to help patients feel more comfortable and reduce the amount of pain medication they need afterward.

To participate in this study, you need to be between 18 and 85 years old and scheduled for the TAVI procedure. However, some people may not be eligible, such as those with certain bleeding conditions, those taking blood thinners, or those with chronic pain issues before the surgery. If you choose to participate, the study will monitor your pain levels, how much medication you need during and after the procedure, and any side effects you might experience. The ultimate goal is to find the best way to keep patients comfortable and safe during this important heart procedure.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients scheduled for TAVİ
• • aged between 18 and 85 years,
• • American Society of Anesthesiology (ASA) physical status II-IV
• Exclusion Criteria:
• • History of bleeding diathesis.
• • Use of anticoagulant therapy.
• • History of chronic pain prior to surgery.
• • Multiple trauma.
• • Conditions where pain assessment cannot be performed (e.g., dementia).
• • Patients operated under spinal or epidural anesthesia.
• • Presence of infection in the region where the block will be applied.
• • Refusal to consent to the procedure